Free Trial
LON:AVO

Advanced Oncotherapy (AVO) Share Price, News & Analysis

Advanced Oncotherapy logo

About Advanced Oncotherapy Stock (LON:AVO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
1.75
1.75
52-Week Range
N/A
Volume
200,000 shs
Average Volume
1.27 million shs
Market Capitalization
£9.50 million
P/E Ratio
N/A
Dividend Yield
5.49%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter.

AVO Stock News Headlines

AVO.L Regulatory News
Banks aren’t ready for this altcoin—are you?
The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.
Advanced Oncotherapy Share Chat
Advanced Oncotherapy PLC AVO
See More Headlines

AVO Stock Analysis - Frequently Asked Questions

Advanced Oncotherapy plc (LON:AVO) announced its earnings results on Monday, June, 29th. The company reported ($9.83) earnings per share for the quarter, missing analysts' consensus estimates of ($8.90) by $0.93.

Shares of AVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Advanced Oncotherapy investors own include UK Oil & Gas (UKOG), Academy Sports and Outdoors (ASO), Renishaw (RSW), Tullow Oil (TLW), BMR Group (BMR), Lancashire (LRE) and Sirius Minerals (SXX).

Company Calendar

Last Earnings
6/29/2020
Today
7/11/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
Agriculture
Current Symbol
LON:AVO
CIK
N/A
Fax
N/A
Employees
3,900
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£32.60 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-67.34%
Return on Assets
-11.73%

Debt

Debt-to-Equity Ratio
98.71
Current Ratio
1.26
Quick Ratio
0.13

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
33.50
Book Value
GBX 14 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
542,570,000
Free Float
N/A
Market Cap
£9.50 million
Optionable
Not Optionable
Beta
0.06
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:AVO) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners